Precision Medicine PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic Bullet Why All Cancer Patients Should Have Access To Genomic Testing 7 Key Cancer Trends For 2018 A New PARP Drug For Breast Cancer? I’m Thrilled! Actually, Many New Cancer Drugs May Be Helpful And Worth Trying A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It Precision Oncology Drug Shows Power Of Cancer Genomics In Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic Changes Bayer’s Stivarga Shows Slim Progress Against Liver Cancer Which Patients Will Be Helped By Immune Cancer Drugs? This Test May Tell A PARP Inhibitor Keeps Some Cancers In Check For Years Encouraging Results For Ribociclib In Advanced Breast Cancer A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology Could New Lung Cancer Meds Keep Walter White From Breaking Bad? Blood Test Offers An Amazing View Of Metastatic Prostate Cancer Cells Five Key Issues For The Future Of Cancer IT Companion Diagnostics? For Cancer Care, We Need Better Ones Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients Precision Medicine Will (Eventually) Lower Cancer Care Costs In A First, Kidney Cancer Drug Extends Survival Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors? The (Unmet) Potential Value of Cancer Genome Testing With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry? Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer A Chip against Cancer: Microfluidics Spots Circulating Tumor Cells
